Home › Free Stock Grades › ERAS
Erasca, Inc. (ERAS) Stock Grade
ERAS · Healthcare
C
Market Cap
$4.9B
P/E Ratio
—
Revenue Growth (YoY)
0.0%
Net Margin
0.0%
Return on Equity
—
Dividend Yield
None
About Erasca, Inc.'s fundamentals
Erasca is a $4.9 billion biotechnology company with no dividend yield. The company reported zero year-over-year revenue growth and a net loss in its latest annual statement, resulting in a net margin of 0.0%. With no earnings to report, traditional valuation metrics like P/E ratio and return on equity are not applicable. As a pre-revenue or early-stage biotech firm, the company's financial performance is typical for the sector during development phases.